What Stocks Are Recession-Proof?
Fears of a recession prevailed in Q2 2025 when the…
Buy
85
EHC Quote, Financials, Valuation and Earnings
Last price:
$117.64
Seasonality move
:
16.76%
Day range:
$115.51 - $118.21
52-week range:
$82.74 - $118.27
Dividend yield:
0.56%
P/E ratio:
24.30x
P/S ratio:
2.18x
P/B ratio:
5.49x
Volume:
604.8K
Avg. volume:
1M
1-year change:
36.47%
Market cap:
$11.9B
Revenue:
$5.4B
EPS (TTM):
$4.84
EHC Analysts' Consensus Rating
The 10 analysts providing 12-month price projections for Encompass Health shares anticipate an average target of $130.09, ranging from a low estimate of $122.00 to a high estimate of $140.00. This average target implies a growth of 10.61% compared to the current stock price of $117.61.
Consensus Price Target
$130.09
Highest Price Target
$140.00
Lowest Price Target
$122.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 11 | 10 | 10 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Buy | Buy |
EHC Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Which Stocks Are Recession-Proof?
Fears of a recession prevailed in Q2 2025 when the…
Is Gartner a Safe Stock to Own?
Gartner (NYSE:IT) is among the world’s largest consulting, research and…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 38x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
70
Is NVDA Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 44x
Alerts
Buy
57
RGC alert for May 14
Regencell Bioscience Holdings [RGC] is down 31.81% over the past day.
Buy
54
HALO alert for May 14
Halozyme Therapeutics [HALO] is down 24.57% over the past day.
Buy
91
COIN alert for May 14
Coinbase Global [COIN] is up 24.64% over the past day.
